AC
AMGN icon

Ascend Capital’s Amgen AMGN Stock Holding History

Ascend Capital’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-78,319
Closed -$11.4M – 141
2016
Q4 		$11.4M Buy
+78,319
New +$11.8M 0.57% 62
2016
Q1 		– Sell
-136,497
Closed -$22.2M – 100
2015
Q4 		$22.2M Buy
+136,497
New +$21.5M 0.78% 45
2015
Q3 		– Sell
-100,675
Closed -$15.5M – 126
2015
Q2 		$15.5M Buy
+100,675
New +$16.1M 0.51% 70
2014
Q3 		– Sell
-100,233
Closed -$11.9M – 175
2014
Q2 		$11.9M Buy
+100,233
New +$11.6M 0.4% 83
2013
Q4 		– Sell
-121,508
Closed -$13.6M – 181
2013
Q3 		$13.6M Buy
121,508
+47,081
+63% +$5.11M 0.51% 65
2013
Q2 		$7.34M Buy
+74,427
New +$7.72M 0.31% 97

Other funds holding AMGN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ascend Capital's AMGN Position: Q1 2017 in Review

Ascend Capital sold out of Amgen (AMGN) in Q1 2017, closing a stake of 78,319 shares — an estimated $11.4M sold.

Ascend Capital first reported a position in AMGN in Q2 2013 and held it in 6 quarters. The position peaked at $22.2M in Q4 2015. 1,600 funds tracked by Wall St. Rank hold AMGN as of Q1 2017.

  • Ascend Capital reported no remaining Amgen position as of Q1 2017 after selling out during the quarter.
  • Ascend Capital sold 78,319 Amgen shares in Q1 2017, an estimated $11.4M.
  • Ascend Capital first reported a position in Amgen in Q2 2013 and held it in 6 quarters.
  • Ascend Capital's Amgen position peaked at $22.2M in Q4 2015.
  • 1,600 funds tracked by Wall St. Rank held Amgen as of Q1 2017.

Based on Ascend Capital's 13F filing for Q1 2017, filed 15 May 2017.